“…In recent studies that were strictly aimed at iNPH patients, the measurement of proteins and neuropeptides in the CSF has been conducted. Neurofilament light chain, 2,136) transforming growth factor (TGF)-b1, TGF-b type II receptor, and a2-leucine-rich glycoprotein (LRG) 84,85) are significantly increased in the CSF of iNPH patients, whereas acetylcholine esterase activity, lactic acid, 87) b-amyloid-42, 60,112) b trace, 26) a secreted form of b-amyloid precursor protein (APP), and a secreted form of APPa 112) were significantly decreased in the CSF of iNPH patients. Since the levels of total tau (t-tau), but not phosphorylated tau (p-tau), were increased in the CSF of iNPH patients, they were reported to be useful in the differential diagnosis of Alzheimer's disease.…”